{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:21:31Z","timestamp":1794244891072,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-6033-2","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T13:03:03Z","timestamp":1566910983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2340-6655","authenticated-orcid":false,"given":"Timothy R.","family":"McGuire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don W.","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Sughroue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl J.","family":"Murry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashpal S.","family":"Chhonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gracey","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"key":"6033_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64:83\u2013103.","journal-title":"CA Cancer J Clin"},{"key":"6033_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.paed.2011.08.005","volume":"22","author":"A Hallett","year":"2012","unstructured":"Hallett A, Traunecker H. A review and update on neuroblastoma. Paediatr Child Health. 2012;22:103\u20137.","journal-title":"Paediatr Child Health"},{"key":"6033_CR3","first-page":"20","volume":"4","author":"S Aminzadeh","year":"2015","unstructured":"Aminzadeh S, Vidali S, Sperl W, Kofler B, Feichtinger RG. Energy metabolism in neuroblastoma and Wilms tumor. Transl Pediatr. 2015;4:20\u201332.","journal-title":"Transl Pediatr"},{"key":"6033_CR4","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","volume":"123","author":"JR Doherty","year":"2013","unstructured":"Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013;123:3685\u201392.","journal-title":"J Clin Invest"},{"key":"6033_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-015-0130-8","volume":"3","author":"AH Chourasia","year":"2015","unstructured":"Chourasia AH, Boland ML, Macleod KF. Mitophagy and cancer. Cancer Metabol. 2015;3:1\u201311.","journal-title":"Cancer Metabol"},{"key":"6033_CR6","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.15252\/embj.201796438","volume":"36","author":"F Dejure","year":"2017","unstructured":"Dejure F, Eilers M. MYC and tumor metabolism: chicken and egg. EMBO J. 2017;36:3409\u201320.","journal-title":"EMBO J"},{"key":"6033_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12915-014-0085-1","volume":"12","author":"N Chandel","year":"2014","unstructured":"Chandel N. Four key questions about metformin and cancer. BMC Biol. 2014;12:85\u20137.","journal-title":"BMC Biol"},{"key":"6033_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/med.21359","volume":"36","author":"R Li","year":"2016","unstructured":"Li R. Marinopyrroles: unique drug discoveries based on marine natural products. Med Res Rev. 2016;36:169\u201389.","journal-title":"Med Res Rev"},{"key":"6033_CR9","unstructured":"Li R, Sebti SM, Liu Y, Qin Y, Song H, Cheng C. Marinopyrrole derivatives and methods of making and using same. U.S. patent no. 2018;9,868,474."},{"key":"6033_CR10","unstructured":"Li R, Sebti SM, Liu Y. Marinopyrrole derivatives as anticancer agents. U.S. patent no. 2016;9,340,501."},{"key":"6033_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1021\/cc100052j","volume":"12","author":"C Cheng","year":"2010","unstructured":"Cheng C, Pan L, Chen Y, Song H, Qin Y, Li R. Total synthesis of (\u00b1) marinopyrrole A and its library as potential antibiotic and anticancer agents. J Comb Chem. 2010;12:541\u20137.","journal-title":"J Comb Chem"},{"key":"6033_CR12","doi-asserted-by":"publisher","first-page":"10224","DOI":"10.1074\/jbc.M111.334532","volume":"287","author":"K Doi","year":"2012","unstructured":"Doi K, Li R, Sung SS, Wu H, Liu Y, Manieri W, et al. Discovery of marinopyrrole A (Maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasome degradation. J Biol Chem. 2012;287:10224\u201335.","journal-title":"J Biol Chem"},{"key":"6033_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/0-306-46872-7_2","volume-title":"Human cell culture","author":"CJ Thiele","year":"1998","unstructured":"Thiele CJ. Neuroblastoma. In: Masters J, editor. Human cell culture, vol. 1. Lancaster: Kluwer Academic; 1998. p. 21\u201353."},{"key":"6033_CR14","doi-asserted-by":"publisher","first-page":"85234","DOI":"10.18632\/oncotarget.19076","volume":"8","author":"M Lodrini","year":"2017","unstructured":"Lodrini M, Sprussel A, Astrahantseff K, Tiburius D, Konschak R, Lode H, et al. Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. Oncotarget. 2017;8:85234\u201351.","journal-title":"Oncotarget"},{"key":"6033_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymeth.2013.03.027","volume":"63","author":"G St. Laurent","year":"2013","unstructured":"St. Laurent G, Shtokalo D, Tackett M, Yang Z, Vyatkin Y, Milos P, et al. On the importance of small changes in RNA expression. Methods. 2013;63:18\u201324.","journal-title":"Methods"},{"key":"6033_CR16","first-page":"1","volume":"357","author":"J Shohet","year":"2017","unstructured":"Shohet J, Foster J. Neuroblastoma. Br Med J. 2017;357:1\u20138.","journal-title":"Br Med J"},{"key":"6033_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejmech.2014.11.035","volume":"90","author":"R Li","year":"2015","unstructured":"Li R, Cheng C, Balasis ME, Liu Y, Garner TP, Daniel KG, et al. Design, synthesis, and evaluation of marinopyrrole derivatives as selective inhibitors of mcl-1 binding to pro-apoptotic Bim and dual Mcl-1\/Bcl-xL inhibitors. Eur J Med Chem. 2015;90:315\u201331.","journal-title":"Eur J Med Chem"},{"key":"6033_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ncb2488","volume":"14","author":"R Perciavalle","year":"2012","unstructured":"Perciavalle R, Stewart D, Koss B, Lynch J, Milasta S, Bathina M, et al. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat Cell Biol. 2012;14:575\u201383.","journal-title":"Nat Cell Biol"},{"key":"6033_CR19","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.4161\/cbt.8.16.8964","volume":"8","author":"BJ Lestini","year":"2009","unstructured":"Lestini BJ, Goldsmith KC, Fluchel MN, Liu X, Chen NL, Goyal B, et al. MCL-1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule BCL-2 family antagonists. Cancer Biol Ther. 2009;8:1587\u201395.","journal-title":"Cancer Biol Ther"},{"key":"6033_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1158\/2159-8290.CD-17-0273","volume":"8","author":"D Rickman","year":"2018","unstructured":"Rickman D, Schulte J, Eilers M. The expanding world of NMYC driven tumors. Cancer Discov. 2018;8:150\u201363.","journal-title":"Cancer Discov"},{"key":"6033_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccell.2016.01.002","volume":"29","author":"J Ham","year":"2016","unstructured":"Ham J, Costa C, Sano R, Lochmann T, Sennott E, Patel, et al. Exploitation of the apoptosis-primed state of MYCN-amplified neuroblastoma to develop a potent and specific targeted therapy combination. Cancer Cell. 2016;29:159\u201372.","journal-title":"Cancer Cell"},{"key":"6033_CR22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.neo.2018.08.002","volume":"20","author":"J Felgenauer","year":"2018","unstructured":"Felgenauer J, Tomino L, Anderson JS, Bopp E, Shah N. Dual BRD4 and AURKA inhibition is synergistic against MYCN amplified and non-amplified neuroblastoma. Neoplasia. 2018;20:965\u201374.","journal-title":"Neoplasia"},{"key":"6033_CR23","doi-asserted-by":"publisher","first-page":"10258","DOI":"10.1073\/pnas.1222404110","volume":"110","author":"H Zirath","year":"2013","unstructured":"Zirath H, Frenzel A, Oliynyk G, Segerstrom L, Westermark UK, Larsson K, et al. MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells. PNAS. 2013;110:10258\u201363.","journal-title":"PNAS"},{"key":"6033_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.tibs.2016.01.001","volume":"41","author":"S Cogliati","year":"2016","unstructured":"Cogliati S, Enriquez J, Scorrano L. Mitochondrial cristae: where beauty meets functionality. Trends Biochem Sci. 2016;41:261\u201373.","journal-title":"Trends Biochem Sci"},{"key":"6033_CR25","doi-asserted-by":"publisher","first-page":"675685","DOI":"10.1016\/j.phrs.2016.10.006","volume":"113","author":"M Daugan","year":"2016","unstructured":"Daugan M, Wojcicki A, Hayer B, Boudy V. Metformin: an anti-diabetic drug to fight cancer. Pharmacol Res. 2016;113:675685.","journal-title":"Pharmacol Res"},{"key":"6033_CR26","first-page":"683","volume":"15","author":"F Zi","year":"2018","unstructured":"Zi F, Zi H, Li Y, He J, Shi Q, Cai Z. Metformin and cancer: an existing drug for cancer prevention and therapy. Oncol Lett. 2018;15:683\u201390.","journal-title":"Oncol Lett"},{"key":"6033_CR27","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.tips.2018.07.006","volume":"39","author":"A Vancura","year":"2018","unstructured":"Vancura A, Bu P, Bhagwat M, Zeng J, Vancurova I. Metformin as an anticancer agent. Trend Pharm Sci. 2018;39:867.","journal-title":"Trend Pharm Sci"},{"key":"6033_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2013.02.038","volume":"705","author":"C Rizos","year":"2013","unstructured":"Rizos C, Elisaf M. Metformin and Cancer. Eur J Pharmacol. 2013;705:96\u2013108.","journal-title":"Eur J Pharmacol"},{"key":"6033_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1042\/BJ20111451","volume":"441","author":"J Lee","year":"2012","unstructured":"Lee J, Giordano S, Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signaling. Biochem J. 2012;441:523\u201340.","journal-title":"Biochem J"},{"key":"6033_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/path.2694","volume":"221","author":"S Barth","year":"2010","unstructured":"Barth S, Glick D, Macleod K. Autophagy: assays and artifacts. J Pathol. 2010;221:117\u201324.","journal-title":"J Pathol"},{"key":"6033_CR31","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1101\/gad.223321.113","volume":"27","author":"K Moriwaki","year":"2013","unstructured":"Moriwaki K, Chan F. RIP3: a molecular switch for necrosis and inflammation. Genes Dev. 2013;27:1640\u20139.","journal-title":"Genes Dev"},{"key":"6033_CR32","first-page":"1835","volume":"57","author":"Y Eguchi","year":"1997","unstructured":"Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 1997;57:1835\u201340.","journal-title":"Cancer Res"},{"key":"6033_CR33","doi-asserted-by":"publisher","first-page":"15798","DOI":"10.1038\/srep15798","volume":"5","author":"H Shin","year":"2015","unstructured":"Shin H, Kwon H, Lee J, Gui X, Achek A, Kim J, et al. Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53. Sci Rep. 2015;5:15798\u2013815.","journal-title":"Sci Rep"},{"key":"6033_CR34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.drudis.2007.07.013","volume":"12","author":"J Dykens","year":"2007","unstructured":"Dykens J, Will Y. The significance of mitochondrial toxicity testing in drug development. Drug Dis Today. 2007;12:777\u201385.","journal-title":"Drug Dis Today"},{"key":"6033_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccell.2017.03.003","volume":"31","author":"L Leanza","year":"2017","unstructured":"Leanza L, Romio M, Becker K, Azzolini M, Trentin L, Manago A, et al. Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo. Cancer Cell. 2017;31:516\u201331.","journal-title":"Cancer Cell"},{"key":"6033_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc3365","volume":"12","author":"DC Wallace","year":"2012","unstructured":"Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012;12:685\u201398.","journal-title":"Nat Rev Cancer"},{"key":"6033_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","volume":"142","author":"J Polivka","year":"2014","unstructured":"Polivka J, Janku F. Molecular targets for cancer therapy in the PI3K\/AKT\/mTOR pathway. Pharmacol Ther. 2014;142:164\u201375.","journal-title":"Pharmacol Ther"},{"key":"6033_CR38","doi-asserted-by":"crossref","first-page":"57525","DOI":"10.18632\/oncotarget.10544","volume":"7","author":"L Vaughn","year":"2016","unstructured":"Vaughn L, Clarke P, Barker K, Chanthery Y, Gustafson C, Tucker E, et al. Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors. Oncotarget. 2016;7:57525\u201344.","journal-title":"Oncotarget"},{"key":"6033_CR39","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1200\/JCO.2010.33.4649","volume":"29","author":"S Spunt","year":"2011","unstructured":"Spunt S, Grupp S, Vik T, Santana V, Greenblatt D, Clancy J, et al. Phase 1 study of temsirolimus in pediatric patients with reccurent\/refractory solid tumors. J Clin Oncol. 2011;29:2933\u201340.","journal-title":"J Clin Oncol"},{"key":"6033_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ejca.2011.09.021","volume":"48","author":"B Geoerger","year":"2012","unstructured":"Geoerger B, Kieran MW, Grupp S, Perek D, Clancy J, Krygowski M, et al. Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma. Eur J Cancer. 2012;48:253\u201362.","journal-title":"Eur J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6033-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6033-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6033-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T23:13:29Z","timestamp":1598397209000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6033-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6033"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6033-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"13 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The use of NSG mice in this experiment was approved by the UNMC IACUC (Protocol#: 13\u2013050-00-Fc).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The co-corresponding authors established consent for publication from co-authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"837"}}